Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc.
WKN: A3DNZ4 / Symbol: RGLS / Name: Regulus Therapeutics / Aktie / Micro Cap /
1,39 €
-4,14 %
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $6.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its price target raised by analysts at HC Wainwright from $9.00 to $10.00. They now have a "buy" rating on the stock.
Ratings data for RGLS provided by MarketBeat
Regulus Therapeutics Inc. (NASDAQ: RGLS) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $7.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
Neueste Beiträge
Alliance_Global_Part in Aspira Womens Health Inc. diskutieren